[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100406295":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":30,"locations":38,"responsibleParty":55,"collaborators":25,"id":58,"slug":25,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":25,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":25,"enrollmentInfo":65,"targetDuration":25,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":41,"whyStopped":25,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"WellSpan Health","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"V-care uterine manipulator","EXPERIMENTAL","Patients in the V-care uterine manipulator arm will undergo standard staging surgery utilizing a V-care uterine manipulator in the standard fashion",[13],"Procedure: surgical staging",{"label":15,"type":16,"description":17,"interventionNames":18},"Sponge stick","ACTIVE_COMPARATOR","Patients in the sponge stick arm will undergo standard staging surgery utilizing a non-invasive sponge stick for cervical delineation.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","surgical staging","Patients will undergo standard surgical staging for endometrial cancer utilizing either a V-care uterine manipulator or sponge stick",[15,9],null,[27],{"name":28,"affiliation":5,"role":29},"Eav Lim, DO","PRINCIPAL_INVESTIGATOR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Graham Brown, DO","CONTACT","717-851-6120","gbrown5@wellspan.org",{"name":28,"role":33,"phone":34,"phoneExt":25,"email":37},"elim@wellspan.org",[39],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Wellspan Health","RECRUITING","York","Pennsylvania","17403","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-76.72774,39.9626,{"lat":51,"lon":50},[54],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},{"type":29,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Eav Lim","Site Director, Gynecology Oncology","100406295",false,"NCT04570553","Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers","Inclusion Criteria:\n\n* Subjects age 18 or older able to give informed consent\n* Biopsy diagnosed endometrial cancer (including endometrioid, serous, mucinous and clear cell histologies)\n* Planned standard of care surgical management of early stage endometrial cancer\n* No clinical evidence of disseminated intraperitoneal disease\n\nExclusion Criteria:\n\n* Final pathology does not reflect diagnosis of endometrial cancer (including endometrioid, serous, mucinous, and clear cell histology)\n* Evidence of disseminated intraperitoneal disease\n* Subject is not a surgical candidate\n* Subject elects for fertility sparing or non-operative management\n* Subject is unable to provide informed consent","FEMALE","18 Years",{"count":66,"type":67},350,"ESTIMATED","INTERVENTIONAL",[70],"NA","This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I\u002FII) endometrial cancer.",[73],"Endometrial Cancer",[75,76],"endometrial cancer","peritoneal cytology","2025-03-24",{"date":79,"type":80},"2025-03-28","ACTUAL",{"date":82,"type":80},"2020-10-15",{"date":84,"type":67},"2027-06-30",{"name":5,"class":6},1]